4/25
06:01 am
lexx
Lexaria Bioscience (LEXX) was upgraded by
Weiss Ratings from "sell (e+)" to "sell (d-)".
Low
Report
Lexaria Bioscience (LEXX) was upgraded by
Weiss Ratings from "sell (e+)" to "sell (d-)".
4/23
09:05 am
lexx
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
Medium
Report
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
4/21
07:57 pm
lexx
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales [Yahoo! Finance]
Low
Report
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales [Yahoo! Finance]
4/15
06:51 am
lexx
Lexaria Bioscience (NASDAQ:LEXX) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
Neutral
Report
Lexaria Bioscience (NASDAQ:LEXX) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
3/26
08:02 pm
lexx
Lexaria's Robust Patent Portfolio Continues to Grow [Yahoo! Finance]
Medium
Report
Lexaria's Robust Patent Portfolio Continues to Grow [Yahoo! Finance]
2/28
05:59 am
lexx
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market [Globe and Mail, The (Toronto, Canada)]
Low
Report
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market [Globe and Mail, The (Toronto, Canada)]
2/28
05:59 am
lexx
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability [Globe and Mail, The (Toronto, Canada)]
Low
Report
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability [Globe and Mail, The (Toronto, Canada)]